Omeros | OMER - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Adma Biologics USD 408.21M 17.88M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
Cytokinetics USD -173.49M 653.08M 2026-06
Gilead Sciences USD 11.74B 11.77B 2026-06
Heron Therapeutics USD 6.91M 2.23M 2026-06
Immunic USD 151.23M 157.91M 2026-03
Insmed USD 757.49M 52.64M 2026-06
Knight Therapeutics CAD 767.27M 480K 2025-12
MacroGenics USD 42.87M 21.68M 2026-06
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 671.98M 18.08M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Rockwell Medical USD 30.41M 1.11M 2025-06
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06
Vertex Pharmaceuticals USD 20.25B 886M 2026-06